$9.45 -0.07 (-0.74%)
11/6/2009 4:00 PM

Seattle Genetics, Inc. (SGEN)

CAPS Rating: 3 out of 5

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

Current Price $9.45 Mkt Cap $823.62M
Open $9.44 P/E Ratio 0.00
Prev. Close $9.52 Div. (Yield) N/A (N/A)
Daily Range $9.24 - $9.71 Volume 537,205
52-Wk Range $7.00 - $14.94 Avg. Daily Vol. 836,000

SGEN News and Commentary

Caps

How do you think SGEN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

277 Outperform
23 Underperform
 

All-Star Members

57 Outperform
9 Underperform
 

Wall Street

10 Outperform
1 Underperform
 

Top SGEN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFBreakerBrian (99.26)
Submitted March 31, 2008

Biopharmaceuticals are being valued at a premium and Seattle Genetics has the goods. Is it the blood cancer biologics version of solid tumor small molecule Exelixis?

0 Comments | Reply | Report this Post

zzlangerhans (99.36)
Submitted July 24, 2008

I have to hand it to the boys from Seattle for keeping their share price up despite a deficiency of late stage trials and a fat burn. Other baby bios in a similar position have had their asses handed to them in this market. But now we're nearing a… More

0 Comments | Reply | Report this Post
SGEN VS S&P 500 (SPY)

Fools bullish on SGEN are also bullish on:

Fools bearish on SGEN are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about SGEN.

Recs

0
Member Avatar dcsccr (< 20) Submitted: 7/10/2009 11:53:34 AM : Outperform Start Price: $8.87 SGEN Score: -15.97

antibodies and their conjugates are the future of cancer therapeutics

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar gokylego (44.82) Submitted: 4/28/2009 11:01:51 PM : Outperform Start Price: $8.98 SGEN Score: -19.90

Partnered well with funding and a intriguing pipeline.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar SpaceMonkey01 (88.46) Submitted: 3/29/2009 12:28:30 PM : Outperform Start Price: $9.61 SGEN Score: -37.43

Moving Average Convergence/Divergence (MACD) indicates a Bullish Trend.
Chart pattern indicates a Strong Upward Trend.
Relative Strength is Bullish.
Up/Down volume pattern indicates that the stock is under Accumulation.
The 50 day Moving Average is rising which is Bullish.
The 200 day Moving Average is rising which is Bullish.
Look for Support at 9.89
Watch for resistance at 10.84

Report this Post 0 Comments | Reply | Permalink
View All 46 Pitches »

Leaderboard

Find the members with the highest scoring picks in SGEN.

Score Leader

jimbospix

jimbospix (97.47) Score: +175.99

The Score Leader is the member with the highest score across all their picks in SGEN.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
lloydvon 69.23 8/30/2006 Outperform 1Y $4.48 +110.94% -12.73% +123.67 1 Comment
Zipsdad < 20 10/4/2006 Outperform 1Y $4.67 +102.36% -14.49% +116.84
twildstar 54.55 10/11/2006 11/11/2006 Outperform 5Y $4.93 +91.68% -16.16% +107.84
vkowalczuk 46.03 10/19/2006 Outperform 1Y $5.10 +85.29% -16.60% +101.90 1 Comment
RAIDERFAN77 57.25 1/3/2007 7/1/2009 Outperform 1Y $5.27 +79.32% -20.06% +99.38
SloopJohnB06 77.57 12/26/2006 Outperform 5Y $5.63 +67.85% -19.25% +87.10
muae1 < 20 12/18/2006 Outperform NS $5.76 +64.06% -20.23% +84.29
biogirl < 20 1/8/2007 Outperform 3M $6.45 +46.53% -19.17% +65.70
opveiby 76.48 1/8/2007 Outperform 1Y $6.46 +46.28% -19.19% +65.47
Turkmenbashi 48.95 1/8/2007 Outperform 3Y $6.59 +43.40% -19.45% +62.85
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackJimCramer < 20 11/4/2009 Underperform 3W $8.95 +5.59% +2.11% -3.48
TrackDeutscheSec 89.50 8/13/2009 Outperform NS $11.25 -16.00% +8.12% -24.12
TrackOppenheimer 26.63 10/27/2008 Outperform NS $8.28 +14.13% +27.07% -12.94
TrackRBCCapMkts 81.74 3/19/2008 Outperform NS $8.63 +9.50% -16.77% +26.27
TrackMichaelBrus 93.35 2/14/2008 Outperform 1Y $9.35 +1.07% -17.40% +18.47
TrackJPMorgan 78.71 1/28/2008 Outperform NS $9.34 +1.18% -16.22% +17.40
TrackFortisBank 86.13 9/21/2007 Outperform NS $11.79 -19.85% -26.50% +6.65
TrackWMBlair 39.74 8/21/2007 Outperform NS $11.03 -14.32% -22.05% +7.72
TrackCarisandCo 78.62 3/8/2007 Outperform NS $7.40 +13.78% -6.58% +20.37 3/13/2008 @ $8.42
TrackRBCCapMkts 81.74 1/9/2007 Outperform NS $6.61 +94.99% +10.50% +84.49 10/15/2007 @ $12.89
TrackBofASec 93.50 12/12/2006 Outperform NS $6.17 +53.16% -19.75% +72.91
TrackNeedham < 20 10/25/2006 Outperform NS $4.92 +92.07% -17.47% +109.55
TrackNextGen 62.38 10/6/2006 Outperform NS $4.95 +90.91% -15.69% +106.60

Featured Broker Partners